IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 167 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $195,986,000 | +115.9% | 2,304,900 | -10.0% | 4.77% | +80.6% |
| Q2 2020 | $90,762,000 | +63.9% | 2,561,000 | -37.7% | 2.64% | +50.4% |
| Q1 2020 | $55,369,000 | +51.9% | 4,107,464 | +138.4% | 1.76% | +51.1% |
| Q4 2019 | $36,451,000 | -14.5% | 1,722,618 | -46.4% | 1.16% | -33.1% |
| Q3 2019 | $42,618,000 | -38.4% | 3,214,000 | -35.5% | 1.74% | -30.0% |
| Q2 2019 | $69,147,000 | -5.1% | 4,985,383 | +31.4% | 2.48% | -11.1% |
| Q1 2019 | $72,898,000 | +178.7% | 3,794,783 | +107.0% | 2.80% | +167.0% |
| Q4 2018 | $26,160,000 | -21.0% | 1,833,202 | +15.3% | 1.05% | -11.7% |
| Q3 2018 | $33,120,000 | +24.4% | 1,590,000 | +41.4% | 1.19% | +26.8% |
| Q2 2018 | $26,624,000 | +95.9% | 1,124,800 | +20.9% | 0.94% | +98.5% |
| Q1 2018 | $13,594,000 | -35.3% | 930,448 | -28.5% | 0.47% | -43.0% |
| Q4 2017 | $21,015,000 | +158.3% | 1,300,448 | +123.4% | 0.83% | +126.0% |
| Q3 2017 | $8,136,000 | +146.8% | 582,000 | -45.8% | 0.37% | +173.1% |
| Q4 2015 | $3,296,000 | -67.6% | 1,073,640 | -57.2% | 0.13% | -60.5% |
| Q2 2015 | $10,174,000 | -11.6% | 2,505,872 | -16.6% | 0.34% | -9.1% |
| Q1 2015 | $11,513,000 | -27.4% | 3,005,972 | -9.1% | 0.37% | -34.6% |
| Q4 2014 | $15,869,000 | +52.0% | 3,305,972 | +17.8% | 0.57% | +50.0% |
| Q3 2014 | $10,438,000 | +1.9% | 2,805,972 | 0.0% | 0.38% | -7.8% |
| Q2 2014 | $10,242,000 | -7.5% | 2,805,972 | +6.7% | 0.41% | -8.8% |
| Q1 2014 | $11,068,000 | – | 2,628,972 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |